A Berkshire County pharmaceutical manufacturer is expanding again. Sharp Sterile Manufacturing, which started as a small ...
As the rapid expansion of biologics continues, today’s high‑concentration injectables, prefilled syringes and cartridges, as ...
Explore how parenteral manufacturing solutions are evolving for specific drug formulations and meeting the demands of ...
Scale-up involves increasing pump sizes, reactor volumes, and flow rates—but the process control logic and system ...
High-performance coatings are a foundational component of cleanroom design, promoting sterility, cleaning efficiency, and ...
Drug developers weigh building internal radiopharmaceutical capabilities versus outsourcing amid timeline and funding ...
Curia, a leading contract research, development and manufacturing organization (CDMO), today announced progress on the expansion at its Glasgow, UK sterile drug ...
The IPO of Sai Parenterals launched today, March 23, saw low investor interest, with just 0.05 times subscription. The ...
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
Agreement for the Commercial Manufacture of Established, Approved Aesthetic Product -- -- Third Commercial Site Transfer ...
The ₹409-crore IPO from Sai Parenterals opens today at a price band of ₹372–392. The Initial Public Offering will close on ...
Representatives of Intercon Chemical Company (Intercon) have announced the introduction of a new portfolio of Branded Products - Cleaner MD and Cleaner LS, expanding the company's brand offerings into ...
Alira Health’s annual CDMO medtech report highlights growth, consolidation, and capability expansion; market projected to reach $143.6B by 2030 at an 8.3% CAGRFRAMINGHAM, Mass., March 31, 2026 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results